» Articles » PMID: 17621700

Role of Placentally Produced Inflammatory and Regulatory Cytokines in Pregnancy and the Etiology of Preeclampsia

Overview
Publisher Springer
Date 2007 Jul 12
PMID 17621700
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Human pregnancy is a metabolic and immune challenge for the mother who has to accommodate in her womb a semi-allogeneic fetus whose energy needs increase tremendously with gestation. Recent compelling research has suggested that proper inflammatory changes and oxidative balance are a requisite for successful pregnancy. The placenta is an integral component of this inflammatory response as it actively produces a variety of cytokines and immunomodulatory hormones. In preeclampsia, a life-threatening disorder of pregnancy that is characterized by widespread damage and dysfunction of the maternal endothelium, placental oxidative stress and aberrant cytokine expression induces an exaggerated maternal systemic inflammatory response to pregnancy.

Citing Articles

Analysis of the evolution of placental oxidative stress research from a bibliometric perspective.

Chen A, Tian M, Luo Z, Cao X, Gu Y Front Pharmacol. 2024; 15:1475244.

PMID: 39484166 PMC: 11524950. DOI: 10.3389/fphar.2024.1475244.


Metabolic theory of preeclampsia: implications for maternal cardiovascular health.

Manoharan M, Montes G, Acquarone M, Swan K, Pridjian G, Nogueira Alencar A Am J Physiol Heart Circ Physiol. 2024; 327(3):H582-H597.

PMID: 38968164 PMC: 11442029. DOI: 10.1152/ajpheart.00170.2024.


MicroRNA-223-3p downregulates the inflammatory response in preeclampsia placenta via targeting NLRP3.

Liu X, Li Z, Lu D BMC Pregnancy Childbirth. 2024; 24(1):175.

PMID: 38448875 PMC: 10918892. DOI: 10.1186/s12884-024-06371-9.


Immune checkpoint molecules B7-1 and B7-H1 as predictive markers of pre-eclampsia: A case-control study in a Ghana.

Akilla M, Nchor I, Banyeh M, Amidu N Immun Inflamm Dis. 2024; 12(1):e1142.

PMID: 38270323 PMC: 10777883. DOI: 10.1002/iid3.1142.


Preeclampsia at term: evidence of disease heterogeneity based on the profile of circulating cytokines and angiogenic factors.

Chaiworapongsa T, Romero R, Gomez-Lopez N, Suksai M, Gallo D, Jung E Am J Obstet Gynecol. 2023; 230(4):450.e1-450.e18.

PMID: 37806612 PMC: 10990810. DOI: 10.1016/j.ajog.2023.10.002.


References
1.
Hahn S, Gupta A, Troeger C, Rusterholz C, Holzgreve W . Disturbances in placental immunology: ready for therapeutic interventions?. Springer Semin Immunopathol. 2006; 27(4):477-93. DOI: 10.1007/s00281-006-0016-5. View

2.
Meisser A, Chardonnens D, Campana A, Bischof P . Effects of tumour necrosis factor-alpha, interleukin-1 alpha, macrophage colony stimulating factor and transforming growth factor beta on trophoblastic matrix metalloproteinases. Mol Hum Reprod. 1999; 5(3):252-60. DOI: 10.1093/molehr/5.3.252. View

3.
Winkler-Lowen B, Guilbert L . Monocytes adhering by LFA-1 to placental syncytiotrophoblasts induce local apoptosis via release of TNF-alpha. A model for hematogenous initiation of placental inflammations. J Leukoc Biol. 2000; 68(6):903-8. View

4.
Burton G, Jauniaux E . Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig. 2004; 11(6):342-52. DOI: 10.1016/j.jsgi.2004.03.003. View

5.
Bennett W, Stopple J, Barber W, Hale E, Brackin M, Cowan B . Cytokine expression by first-trimester human chorionic villi. Am J Reprod Immunol. 1998; 40(5):309-18. DOI: 10.1111/j.1600-0897.1998.tb00059.x. View